A SARS-CoV-2 vaccine designed for manufacturability results in unexpected potency and non-waning humoral response
E. Campbell, J. Dobkin, L. Osorio, S. Ramasamy, R. Kumar, D. B. SantAngelo, S. Subbian, L. K. Denzin, S. Anderson
This paper describes a SARS-CoV-2 vaccine, MT-001, that provides durable, broad, and potent immunity without waning or requiring boosting.
bioRxiv · Feb 6, 2023Immunology